Displaying publications 41 - 60 of 212 in total

Abstract:
Sort:
  1. Paynter S, Ware RS, Weinstein P, Williams G, Sly PD
    Lancet, 2010 Nov 27;376(9755):1804-5.
    PMID: 21111894 DOI: 10.1016/S0140-6736(10)62141-1
  2. Shetty P
    Lancet, 2013 May 18;381(9879):1709-10.
    PMID: 23691551
  3. Wolfe D, Carrieri MP, Shepard D
    Lancet, 2010 Jul 31;376(9738):355-66.
    PMID: 20650513 DOI: 10.1016/S0140-6736(10)60832-X
    We review evidence for effectiveness, cost-effectiveness, and coverage of antiretroviral therapy (ART) for injecting drug users (IDUs) infected with HIV, with particular attention to low-income and middle-income countries. In these countries, nearly half (47%) of all IDUs infected with HIV are in five nations--China, Vietnam, Russia, Ukraine, and Malaysia. In all five countries, IDU access to ART is disproportionately low, and systemic and structural obstacles restrict treatment access. IDUs are 67% of cumulative HIV cases in these countries, but only 25% of those receiving ART. Integration of ART with opioid substitution and tuberculosis treatment, increased peer engagement in treatment delivery, and reform of harmful policies--including police use of drug-user registries, detention of drug users in centres offering no evidence-based treatment, and imprisonment for possession of drugs for personal use--are needed to improve ART coverage of IDUs.
  4. Saleem F, Hassali MA, Iqbal Q, Baloch M, Shanker PR
    Lancet, 2016 11 26;388(10060):2602.
    PMID: 27832869 DOI: 10.1016/S0140-6736(16)32120-1
  5. Yadav M, Shah FH
    Lancet, 1973 Aug 25;2(7826):450-1.
    PMID: 4124938
  6. Touraine M, Gröhe H, Coffie RG, Sathasivam S, Juan M, Louardi el H, et al.
    Lancet, 2014 Sep 27;384(9949):1161-2.
    PMID: 25242037 DOI: 10.1016/S0140-6736(14)61419-7
  7. Nassiri-Ansari T, Atuhebwe P, Ayisi AS, Goulding S, Johri M, Allotey P, et al.
    Lancet, 2022 Jul 02;400(10345):24.
    PMID: 35780789 DOI: 10.1016/S0140-6736(22)01189-8
  8. Hanbali L, Lehtimaki S, Hannon E, McNab C, Schwalbe N
    Lancet, 2023 Feb 18;401(10376):553.
    PMID: 36736333 DOI: 10.1016/S0140-6736(23)00126-5
  9. Aars OK, Schwalbe N
    Lancet, 2023 Sep 02;402(10404):771-772.
    PMID: 37659773 DOI: 10.1016/S0140-6736(23)01414-9
  10. Beyrer C, Kamarulzaman A, Isbell M, Amon J, Baral S, Bassett MT, et al.
    Lancet, 2024 Apr 06;403(10434):1374-1418.
    PMID: 38522449 DOI: 10.1016/S0140-6736(24)00302-7
  11. Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K
    Lancet, 2018 05 12;391(10133):1927-1938.
    PMID: 29550029 DOI: 10.1016/S0140-6736(18)30458-6
    As global efforts accelerate to implement the Sustainable Development Goals and, in particular, universal health coverage, access to high-quality and timely pathology and laboratory medicine (PALM) services will be needed to support health-care systems that are tasked with achieving these goals. This access will be most challenging to achieve in low-income and middle-income countries (LMICs), which have a disproportionately large share of the global burden of disease but a disproportionately low share of global health-care resources, particularly PALM services. In this first in a Series of three papers on PALM in LMICs, we describe the crucial and central roles of PALM services in the accurate diagnosis and detection of disease, informing prognosis and guiding treatment, contributing to disease screening, public health surveillance and disease registries, and supporting medical-legal systems. We also describe how, even though data are sparse, these services are of both insufficient scope and inadequate quality to play their key role in health-care systems in LMICs. Lastly, we identify four key barriers to the provision of optimal PALM services in resource-limited settings: insufficient human resources or workforce capacity, inadequate education and training, inadequate infrastructure, and insufficient quality, standards, and accreditation.
  12. Kok A, Robinson MJ
    Lancet, 1976 Sep 18;2(7986):633.
    PMID: 61371
  13. Stocking B, Gostin L, Halton J, Saavedra J, Garcia P, Baptiste Leite R, et al.
    Lancet, 2023 Jun 17;401(10393):2035.
    PMID: 37330736 DOI: 10.1016/S0140-6736(23)01065-6
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links